1. Home
  2. CTMX vs CMU Comparison

CTMX vs CMU Comparison

Compare CTMX & CMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • CMU
  • Stock Information
  • Founded
  • CTMX 2008
  • CMU 1987
  • Country
  • CTMX United States
  • CMU United States
  • Employees
  • CTMX N/A
  • CMU N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • CMU Investment Managers
  • Sector
  • CTMX Health Care
  • CMU Finance
  • Exchange
  • CTMX Nasdaq
  • CMU Nasdaq
  • Market Cap
  • CTMX 85.3M
  • CMU 89.6M
  • IPO Year
  • CTMX 2015
  • CMU N/A
  • Fundamental
  • Price
  • CTMX $0.84
  • CMU $3.55
  • Analyst Decision
  • CTMX Buy
  • CMU
  • Analyst Count
  • CTMX 6
  • CMU 0
  • Target Price
  • CTMX $5.77
  • CMU N/A
  • AVG Volume (30 Days)
  • CTMX 847.0K
  • CMU 82.4K
  • Earning Date
  • CTMX 03-10-2025
  • CMU 01-01-0001
  • Dividend Yield
  • CTMX N/A
  • CMU 4.08%
  • EPS Growth
  • CTMX N/A
  • CMU N/A
  • EPS
  • CTMX 0.16
  • CMU 0.07
  • Revenue
  • CTMX $126,617,000.00
  • CMU N/A
  • Revenue This Year
  • CTMX $22.55
  • CMU N/A
  • Revenue Next Year
  • CTMX N/A
  • CMU N/A
  • P/E Ratio
  • CTMX $5.20
  • CMU $47.57
  • Revenue Growth
  • CTMX 33.66
  • CMU N/A
  • 52 Week Low
  • CTMX $0.79
  • CMU $2.78
  • 52 Week High
  • CTMX $5.85
  • CMU $3.38
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 45.15
  • CMU 55.53
  • Support Level
  • CTMX $0.82
  • CMU $3.50
  • Resistance Level
  • CTMX $0.98
  • CMU $3.58
  • Average True Range (ATR)
  • CTMX 0.06
  • CMU 0.02
  • MACD
  • CTMX 0.01
  • CMU 0.01
  • Stochastic Oscillator
  • CTMX 33.58
  • CMU 66.67

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About CMU MFS Municipal Income Trust

Mfs High Yield Municipal Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.

Share on Social Networks: